Oncology Institute (NASDAQ: TOI) 10% owner buys 20,000 shares in open market

Rhea-AI Filing Summary

Oncology Institute, Inc. ten percent owner Jorey Chernett reported an open-market purchase of common stock. On April 9, 2026, Chernett bought 20,000 shares at $3.10 per share. After this purchase, Chernett directly owned 10,499,358 common shares.

Insider Trade Summary

Net Buyer: 20,000 shares ($62,000)

Net Buy 1 txn

Insider Chernett Jorey

Role 10% Owner

Bought 20,000 shs ($62K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	20,000	$3.10	$62K

Holdings After Transaction: Common Stock — 10,499,358 shares (Direct)

Footnotes (1)

Key Figures

Shares purchased: 20,000 shares Purchase price: $3.10 per share Shares owned after: 10,499,358 shares +1 more

4 metrics

Shares purchased 20,000 shares Open-market common stock purchase on April 9, 2026

Purchase price $3.10 per share Price paid for TOI common stock in the reported trade

Shares owned after 10,499,358 shares Direct common stock holdings after the transaction

Net buy shares 20,000 shares Net change from reported Form 4 transactions

Key Terms

Form 4, open-market purchase, ten percent owner, non-derivative

4 terms

Form 4 regulatory

"disclosed in the Form 4 filing"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

open-market purchase financial

"reported an open-market purchase of common stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

ten percent owner financial

"Ten percent owner Jorey Chernett bought 20,000"

non-derivative financial

"The reported TOI insider transaction involved non-derivative securities"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oncology Institute, Inc. [ TOI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/09/2026		P		20,000	A	$3.1	10,499,358	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jorey Chernett	04/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did TOI’s Jorey Chernett report?

Jorey Chernett reported an open-market purchase of 20,000 shares of Oncology Institute, Inc. common stock. The transaction occurred at a price of $3.10 per share, increasing his directly held position reported in this filing.

When did the TOI insider purchase take place?

The insider purchase took place on April 9, 2026. On that date, ten percent owner Jorey Chernett bought 20,000 shares of Oncology Institute, Inc. common stock in an open-market transaction at $3.10 per share.

What price did the TOI insider pay for the shares?

The TOI insider paid $3.10 per share for the 20,000 shares of common stock. This price reflects the cost per share in the reported open-market purchase made by ten percent owner Jorey Chernett on April 9, 2026.

How many TOI shares does Jorey Chernett hold after the transaction?

After the reported transaction, Jorey Chernett directly holds 10,499,358 shares of Oncology Institute, Inc. common stock. This total reflects his position immediately following the open-market purchase of 20,000 shares disclosed in the Form 4 filing.

Was the TOI insider transaction a buy or a sell?

The transaction was a buy. Ten percent owner Jorey Chernett executed an open-market purchase of 20,000 Oncology Institute, Inc. common shares at $3.10 each, increasing his directly held stake as reported in the Form 4.

Is the TOI insider transaction in derivative or common stock?

The reported TOI insider transaction involved non-derivative securities, specifically common stock. Jorey Chernett bought 20,000 common shares in an open-market purchase, and no derivative securities such as options or warrants were reported in this filing.